Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

5 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

CLL Follow-Up Treatments NCT00090051 BO17072 - Follow-Up Subsequent treatments for Chronic Lymphocytic Leukemia NCT00090051 BO17072

- 28/10/15 - 1 formulario, 4 itemgroups, 16 items, 1 idioma
Itemgroups: Subsequent treatments chemotherapy, Subsequent treatments radiotherapy, Surgery, Other treatment
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). NCT00090051 BO17072

CALGB: 90401 FOLLOW-UP FORM NCT00110214

- 8/6/15 - 1 formulario, 12 itemgroups, 70 items, 1 idioma
Itemgroups: Header, Patient demographics, VITAL STATUS, Disease Assessment, DISEASE RESPONSE, DISEASE PROGRESSION, LHRH Agonist, Notice of New Primary, LONG-TERM TOXICITY, NON-PROTOCOL THERAPY, COMPLETE SECTION BELOW UNTIL PROGRESSION, Footer
CALGB: 90401 FOLLOW-UP FORM NCT00110214 Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=EFB2FF09-853B-4EB3-E034-0003BA3F9857

Bladder Cancer NCT00014534 Treatment - CALGB: 90104 Treatment and Follow-up Form - 2169531v3.0 - CALGB: 90104 Treatment and Follow-up Form

- 9/1/15 - 1 formulario, 1 itemgroup, 61 items, 1 idioma
Itemgroup: CCRR MODULE
CALGB: 90104 Treatment and Follow-up Form Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B6072-F2CE-7116-E034-0003BA12F5E7

Radiation Therapy Oncology Group Initial Follow-up Form Phase III Lung Prophylactic Cranial RT NCT00048997

- 20/9/21 - 1 formulario, 3 itemgroups, 46 items, 1 idioma
Itemgroups: Header Module, Medical history, Comments
Radiation Therapy Oncology Group Initial Follow-up Form Phase III Lung Prophylactic Cranial RT Radiation Therapy in Preventing CNS Metastases in Patients With Non-Small Cell Lung Cancer NCT00048997 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9EC372A6-7094-05D5-E034-080020C9C0E0

NCT00936390 RTOG 0815 F0: Radiation Therapy Oncology Group Phase III Randomized Study of Dose- Escalated Radiotherapy With/Without STAD for Intermediate-Risk Prostate Cancer Initial Follow-up Form

- 5/7/15 - 1 formulario, 16 itemgroups, 74 items, 1 idioma
Itemgroups: Header, Vital status, Prostate Biopsy, Neoplasm recurrence, PROSTATE: PSA MEASUREMENTS, Treatment Schedule (LHRH Agonist), TREATMENT SCHEDULE (ORAL ANTIANDROGEN), Lab Values, Lab Values, CBC/diff, SGPT (ALT) or SGOT (AST), Alkaline Phosphatase, Non-protocol Therapy, Primary cancer, Adverse Events, Comments
NCT00936390 RTOG 0815 F0: Radiation Therapy Oncology Group Phase III Randomized Study of Dose- Escalated Radiotherapy With/Without STAD for Intermediate-Risk Prostate Cancer Initial Follow-up Form Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=655253E9-5F19-860D-E040-BB89AD434872

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial